María Paz Badia , Tomás Abudarham , Soledad Kleppe , Sebastián Malleza , Daniel Matusevich , José Faccioli
{"title":"Errores congénitos del metabolismo y neuropsiquiatría: revisión bibliográfica a propósito de un caso","authors":"María Paz Badia , Tomás Abudarham , Soledad Kleppe , Sebastián Malleza , Daniel Matusevich , José Faccioli","doi":"10.1016/j.psiq.2021.100336","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><p>The purpose of this article is to review the available literature that links inborn errors of metabolism (IEM) with neuropsychiatry, highlighting some guiding points to facilitate suspicion, diagnosis, and treatment.</p></div><div><h3>Case report</h3><p>We describe the case of a male patient who was admitted to the psychiatric ward of a general hospital for presenting atypical psychiatric symptoms. He received treatment with valproic acid (VPA) and developed toxicity together with persistent adverse effects, which lasted even after the drug was withdrawn. Through different blood and urine analyses, it was possible to identify a state of chronic hyperammonemia. Together with the patient's clinical presentation, this result led to the presumptive diagnosis of a metabolic disease related to a urea cycle disorder.</p></div><div><h3>Results</h3><p>IEM can be suspected in young people or adults when they have a positive family history of the disease or when there is the presence of psychiatric symptoms together with neurological, cognitive, or motor signs.</p></div><div><h3>Conclusions</h3><p>IEMs represent a group of genetic diseases in which early diagnosis and treatment can improve the morbidity and mortality of affected patients.</p></div>","PeriodicalId":39337,"journal":{"name":"Psiquiatria Biologica","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psiquiatria Biologica","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1134593421000452","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives
The purpose of this article is to review the available literature that links inborn errors of metabolism (IEM) with neuropsychiatry, highlighting some guiding points to facilitate suspicion, diagnosis, and treatment.
Case report
We describe the case of a male patient who was admitted to the psychiatric ward of a general hospital for presenting atypical psychiatric symptoms. He received treatment with valproic acid (VPA) and developed toxicity together with persistent adverse effects, which lasted even after the drug was withdrawn. Through different blood and urine analyses, it was possible to identify a state of chronic hyperammonemia. Together with the patient's clinical presentation, this result led to the presumptive diagnosis of a metabolic disease related to a urea cycle disorder.
Results
IEM can be suspected in young people or adults when they have a positive family history of the disease or when there is the presence of psychiatric symptoms together with neurological, cognitive, or motor signs.
Conclusions
IEMs represent a group of genetic diseases in which early diagnosis and treatment can improve the morbidity and mortality of affected patients.
期刊介绍:
Es la Publicación Oficial de la Sociedad Española de Psiquiatría Biológica. Los recientes avances en el conocimiento de la bioquímica y de la fisiología cerebrales y el progreso en general en el campo de las neurociencias han abierto el camino al desarrollo de la psiquiatría biológica, fundada sobre bases anatomofisiológicas, más sólidas y científicas que la psiquiatría tradicional.